<DOC>
	<DOCNO>NCT01487811</DOCNO>
	<brief_summary>This trial conduct United state America ( USA ) . The aim trial compare two formulation biphasic insulin aspart 30 healthy volunteer .</brief_summary>
	<brief_title>Comparison Two Biphasic Insulin Aspart 30 Formulations ( Current New Formulation ) Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>BMI ( body mass index ) 18 28 kg/m^2 , inclusive Subject nonsmoker least 3 month Subject judge good health basis medical history , physical examination , ECG ( electrocardiogram ) , routine laboratory data Fasting plasma glucose 80 110 mg/dl •Any clinically significant disease history systemic organ disease •Clinically significant abnormality prestudy clinical examination laboratory measurement screen ( abnormality discuss clinical monitor ) •In female child bear potential : Pregnancy , lactating , breastfeeding , intent become pregnant within next 6months judge use inadequate contraceptive measure ( adequate contraceptive measure include : condom , intrauterine device ) . ßhCG pregnancy test must negative</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>